Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Super Micro Computer Inc (SMCI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Super Micro Computer Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.73 (market cap $4.59B), while Super Micro Computer Inc trades at $41.96 (market cap $28.10B). The key difference: Super Micro Computer Inc is far larger — about 6.1× Definium Therapeutics Inc. Common Shares's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Super Micro Computer Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Super Micro Computer Inc for 19 Days on average.
| DFTX | SMCI | |
|---|---|---|
Market Cap | $4.59B | $28.10B |
Volume | 2,103,937 | 38,581,805 |
Sector | Health | Technology |
52-Week High | $48.45 | $57.98 |
52-Week Low | $10.68 | $20.53 |
Typical Hold Time | 0 Days | 19 Days |
Enterprise Value | $3.55B | $33.56B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Super Micro Computer (SMCI) trades at $44.95, up 3.43% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with revenue growth from $22B to $39.1B projected for 2026, net income margin expansion to 5.7%, and consistent earnings beats. Recent AI server demand and NVIDIA Vera Rubin shipments highlight business momentum, though RSI levels suggest potential near-term overbought conditions.
SMCI presents a compelling growth story with AI infrastructure expansion driving financial performance, trading at attractive valuations (P/E 13.12, P/S 0.76). However, investors face risks including margin pressure, competitive AI server market dynamics, and ongoing regulatory investigation. Analyst consensus remains mixed with 36% buy ratings despite price target below current levels at $42.33.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Super Micro Computer Inc
Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →
